References
- Wilson PWF, Kannel WB, Anderson KM. Lipids, glucose intolerance and vascular disease: The Framingham study. Monogr Atheroscler 1985; 13: 1–11.
- Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: Harris MI, Cowie CC, Stern MP, et al., editors. Diabetes in America. Bethesda, MD: National Institutes of Health, 1995; 429–48.
- Abrams JJ, Ginsberg H, Grundy SM. Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes 1982; 31: 903–10.
- Hernandez C, Garcia-Pascual L, Chacon P, Simo R. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients. Diabetes Care 2001; 24: 350–5.
- Rainwater DL. Lp(a) concentrations are related to plasma lipid concentrations. Atherosclerosis 1996; 127: 13–8.
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. New Engl J Med 1999; 340: 448–54.
- Haffner SM, Tuttle KR, Rainwater DL. Lack of change of lipoprotein (a) concentration with improved glycaemic control in subjects with type 2 diabetes. Metabolism 1992; 41: 116–20.
- Haffner SM. Management of dyslipidaemia in adults with diabetes. Diabetes care risk factors in patients with type 2 diabetes. Diabetes Care 1996; 16: 64–6.
- Garg A. Dyslipoproteinaemia and diabetes. Endocrinol Metab Clin North Am 1998; 27: 613–25.
- Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 2000; 29: 683–705.
- Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent advances and future directions. Clin Chem 2003; 49: 1785–96.